We are live on ! Find out more
OSCR icon

Oscar Health

332 hedge funds and large institutions have $3.61B invested in Oscar Health in 2025 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 120 increasing their positions, 88 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 52

48% more capital invested

Capital invested by funds: $2.45B → $3.61B (+$1.17B)

43% more funds holding in top 10

Funds holding in top 10: 710 (+3)

36% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 88

14% more funds holding

Funds holding: 292332 (+40)

9% more call options, than puts

Call options by funds: $257M | Put options by funds: $236M

9.87% less ownership

Funds ownership: 86.79%76.92% (-9.9%)

Holders
332
Holders Change
+40
Holders Change %
+13.7%
% of All Funds
4.37%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.13%
New
94
Increased
120
Reduced
88
Closed
52
Calls
$257M
Puts
$236M
Net Calls
+$21.1M
Net Calls Change
+$4.21M
Name Holding Trade Value Shares
Change
Change in
Stake
QC
51
Quadrature Capital
United Kingdom
$10.7M +$7.07M +475,725 +1,974%
SC
52
Sessa Capital
New York
$10.7M +$7.43M +500,000 New
AI
53
Alphabet Inc
California
$10.3M
BHCM
54
Brevan Howard Capital Management
Jersey
$9.97M +$6.24M +419,927 +927%
FA
55
Fiduciary Alliance
South Carolina
$9.72M +$6.56M +441,188 +3,558%
RC
56
RBF Capital
California
$9.64M
PP
57
PDT Partners
New York
$9.1M +$1.95M +130,896 +45%
Fidelity Investments
58
Fidelity Investments
Massachusetts
$8.57M +$1.82M +122,112 +44%
Verition Fund Management
59
Verition Fund Management
Connecticut
$8.48M +$5.37M +361,266 +1,057%
BPWM
60
BCS Private Wealth Management
New Jersey
$8.03M +$5.57M +374,579 New
FAM
61
Fred Alger Management
New York
$7.98M -$3.01M -202,191 -35%
Barclays
62
Barclays
United Kingdom
$7.91M +$1.43M +96,165 +35%
Two Sigma Advisers
63
Two Sigma Advisers
New York
$7.65M +$1.76M +118,600 +50%
IMC Chicago
64
IMC Chicago
Illinois
$7.48M +$2.86M +192,344 +123%
TD Asset Management
65
TD Asset Management
Ontario, Canada
$7.13M -$5.07M -340,742 -51%
Swiss National Bank
66
Swiss National Bank
Switzerland
$7.04M
RPAM
67
Rhenman & Partners Asset Management
Sweden
$6.69M -$10.6M -710,651 -69%
Jane Street
68
Jane Street
New York
$6.4M -$295K -19,854 -6%
First Trust Advisors
69
First Trust Advisors
Illinois
$6.27M +$277K +18,627 +7%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$6.07M -$61.8K -4,158 -1%
Skandinaviska Enskilda Banken (SEB)
71
Skandinaviska Enskilda Banken (SEB)
Sweden
$6.04M +$1.54M +103,500 +58%
Group One Trading
72
Group One Trading
Illinois
$6.03M +$2.64M +177,470 +171%
GEH
73
General Equity Holdings
New York
$5.79M
Invesco
74
Invesco
Georgia
$5.42M +$116K +7,801 +3%
AllianceBernstein
75
AllianceBernstein
Tennessee
$5.16M -$38.7K -2,600 -1%

OSCR Hedge Fund Activity: Q2 2025 in Review

332 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q2 2025, worth a combined $3.61B — up 48% from $2.45B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new OSCR positions and 52 closed out — a net gain of 42 holders — while 120 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $25.6M. The largest seller was Dragoneer Investment Group, cutting an estimated $82.8M.

  • 332 institutional investors held Oscar Health (OSCR) as of Q2 2025, up from 292 in Q1 2025.
  • Funds reported $3.61B of Oscar Health stock for Q2 2025, up 48% quarter-over-quarter.
  • 94 funds opened new Oscar Health positions in Q2 2025 and 52 closed out, a net change of +42 holders.
  • The largest Oscar Health buyer in Q2 2025 was Morgan Stanley, an estimated $25.6M added.
  • The largest Oscar Health seller in Q2 2025 was Dragoneer Investment Group, an estimated $82.8M sold.

Based on aggregated 13F filings for Q2 2025.